Today FDA continued its trend of authorizing the sale of tobacco-flavored eicgs — this time the NJOY while leaving menthol versions on the market by not acting. On the NJOY website, menthol and tobacco pods are sold side-by-side, with menthol shown first (screen shot below).
Following the precedent set when it authorized the sale of Logic, rather than addressing the serious scientific problems in its earlier authorization of Vuse Solo, FDA did not publish the full Technical Project Lead (TPL) document detailing the scientific justification for its decision. As with Logic, FDA only released 4 (of the 44) TPL pages, most of which was the same boilerplate about legal requirements that they published for Logic.
In particular, there are no specifics on how many youth they are willing to addict to nicotine as part of FDA’s chasing the golden fleece of smokers “completely switching” to e-cigs in the face of strong and consistent evidence that, over the long run on a population level, e-cigarettes make it harder to quit smoking.
So much for transparency.